A clinical investigation of the mechanism of loxoprofen, a non-steroidal anti-inflammatory drug, for patients with nocturia

Acta Medica Okayama

Volumn 62, Issue 6, 2008, Pages

  Araki, Tohru ^a   Yokoyama, Teruhiko ^b   Araki, Motoo ^c   Furuya, Seiji ^d  

^a Araki Urological Clinic   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

^d Furuya Hospital   (Japan)

Author keywords

Loxoprofen; Nocturia; NSAID

Indexed keywords

LOXOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLPROPIONIC ACID DERIVATIVE;

AGED; ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; MALE; MEDICAL RECORD; MIDDLE AGED; NOCTURIA; PATHOPHYSIOLOGY; TREATMENT OUTCOME; URINE;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; HUMANS; MALE; MEDICAL RECORDS; MIDDLE AGED; NOCTURIA; PHENYLPROPIONATES; TREATMENT OUTCOME; URINE;

EID: 58149462486     PISSN: 0386300X     EISSN: 0386300X     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Stewart RB, Moore MT, May FE and Hale WE: Nocturia: a risk factor for falls in elderly. J Am Geriatr Soc (1992) 40: 1217-1220.
2. Resnick NM and Yalla SV: Geriatric incontinence and voiding dysfunction; in Campbell-Walsh Urology, Wein AJ, Kavoussi LR, Novick AC, Partin AW and Peters CA eds, 9th Ed, Saunders Elsevier, Philadelphia (2007) pp 2305-2321.
3. Araki T, Yokoyama T and Kumon H: Effectiveness of a nonsteroidal anti-inflammatory drug for nocturia on patients with benign prostatic hyperplasia: A prospective non-randomized study of loxoprofen sodium 60 mg once daily before sleeping. Acta Med Okayama (2004) 58: 45-49.
4. Araki T and Yokoyama T: Clinical efficacy of loxoprofen sodium for nocturia on patients with neurogenic bladder: A non-randomized study of loxoprofen 60 mg once daily before sleeping. Rinsho Iyaku (J Clin Therap Med) (2005) 21: 89-95.
5. Al-Waili NS: Indomethacin suppository: An alternative treatment for nocturnal frequency of micturition. IRCS Med Sci (1986) 14: 322-323.
6. Al-Waili NS: Increase urinary nitrite excretion in primary enuresis: effects of indomethacin treatment on urinary and serum osmolality and electrolytes, urinary volumes and nitrite excretion. BJU Int (2002) 90: 294-301.
7. Al-Waili NS: Indomethacin suppository to treat primary nocturnal enuresis: Double-blind study. J Urol (1989) 142: 1290-1292.
8. Le Fanu J: The value of asprin in controlling the symptoms of nocturnal polyuria. BJU Int (2001) 88: 126-127.
9. Addla SK, Adeyoju AB, Neilson D and O'Reilly P: Diclofenac for treatment of nocturia caused by nocturnal polyuria: A prospective, randomized, double blind, placebo-controlled crossover study. Eur Urol (2006) 49: 720-726.
10. Saito M, Kawatani M, Kinoshita Y, Satoh K and Miyagawa I: Effectiveness of an anti-inflammatory drug, loxoprofen, for patients with nocturia. Int J Urol (2005) 12: 779-782.
11. Al-Waili NS, Al-Waili TN, Al-Waili AN and Saloom KY: Urinary nitrite excretion and urinary variables in patients with primary nocturnal frequency of micturition: effects of indomethacin suppositories. World J Urol (2005) 23: 287-294.
12. Hebert RL, Jacobson MR, Fredin D and Breyer MD: Evidence that separate PGE2 receptor modulate water and sodium transport in rabbit cortical collecting duct. Am J Physiol (1993) 265: 643-650.
13. Wen SF: Nephrotoxicities of nonsteroidal anti-inflammatory drugs. J Formos Med Assoc (1997) 96: 157-171.
14. Cardozo LD and Stanton SL: A comparison between bromocriptine and indomethacin in the treatment of detrusor instability. J Urol (1980) 123: 399-401.
15. Cardozo LD, Stanton SL, Robbinson H and Hole D: Evaluation on flurbiprofen in detrusor instability. Br Med J (1980) 280: 281-282.
16. Palmer J: Report of a double-blind crossover study of flurbiprofen and placebo in detrusor instability. J Int Med Res (1983) 11: 11-17.
17. Andersson KE, Ek A and Persson CGA: Effects of prostaglandins on the isolated human bladder and urethra. Acta Physiol Scand (1977) 100: 165-171.
18. Andersson KE and Sjogren C: Aspects of the physiology and pharmacology of the bladder and urethra. Prog Neurobiol (1982) 19: 71-89.
19. Palea S, Toson G, Pietra C, Trist DG, Artibani W, Romano O and Corsi M: Pharmacological characterization of thromboxane and prostanoid receptors in human isolated urinary bladder. Br J Pharmacol (1988) 124: 865-872.
20. Urade Y and Hayaishi O: Prostaglandin D2 and sleep regulation. Biochim Biophys Acta (1999) 1436: 606-615.
21. Wolfe MM, Lichtenstein DR and Singh G. : Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med (1999) 340: 1888-1899.